Abstract:ABSTRACT Invasive aspergillosis (IA) is a common and deadly mold infection in immunocompromised patients. As morbidity and mortality of IA are primarily driven by poor immune defense, adjunct immunotherapies, such as chimeric antigen receptor (CAR) T cells, are direly needed. Here, we propose a novel approach to generate Aspergillus fumigatus (AF)-CAR T cells using the single-chain variable fragment domain of monoclonal antibody AF-269-5 and a lentiviral vector system. These cells successfully targeted mature hyphal filaments of representative clinical and reference AF isolates and elicited a potent release of cytotoxic effectors and type 1 T cell cytokines. Furthermore, AF-CAR T cells generated from peripheral blood mononuclear cells of four healthy human donors and expanded with either of three cytokine stimulation regimens (IL-2, IL-2 + IL-21, or IL-7 + IL-15) significantly suppressed mycelial growth of AF-293 after 18 hours of co-culture and synergized with the immunomodulatory antifungal agent caspofungin to control hyphal growth for 36 hours. Moreover, cyclophosphamide-immunosuppressed NSG mice with invasive pulmonary aspergillosis that received two doses of 5 million AF-CAR T cells (6 and 48 hours after AF infection) showed significantly reduced morbidity on day 4 post-infection ( P < 0.001) and significantly improved 7-day survival ( P = 0.049) compared with mice receiving non-targeting control T cells, even without concomitant antifungal chemotherapy. In conclusion, we developed a novel lentiviral strategy to obtain AF-CAR T cells with high targeting efficacy, yielding significant anti-AF activity in vitro and short-term protection in vivo . Our approach could serve as an important steppingstone for future clinical translation of antifungal CAR T-cell therapy after further refinement and thorough preclinical evaluation. IMPORTANCE Invasive aspergillosis (IA) remains a formidable cause of morbidity and mortality in patients with hematologic malignancies and those undergoing hematopoietic stem cell transplantation. Despite the introduction of several new Aspergillus -active antifungals over the last 30 years, the persisting high mortality of IA in the setting of continuous and profound immunosuppression is a painful reminder of the major unmet need of effective antifungal immune enhancement therapies. The success of chimeric antigen receptor (CAR) T-cell therapy in cancer medicine has inspired researchers to translate this approach to opportunistic infections, including IA. Aiming to refine anti- Aspergillus CAR T-cell therapy and improve its feasibility for future clinical translation, we herein developed and validated a novel antibody-based CAR construct and lentiviral transduction method to accelerate the production of CAR T cells with high targeting efficacy against Aspergillus fumigatus . Our unique approach could provide a promising platform for future clinical translation of CAR T-cell-based antifungal immunotherapy.

Generation and expansion of Aspergillus fumigatus specific T cells in vitro

Identification of Immunogenic Antigens from Aspergillus Fumigatus by Direct Multiparameter Characterization of Specific Conventional and Regulatory CD4+ T Cells.

Generation of IgE-specific Cytotoxic T Lymphocytes As a Novel Immunotherapeutic Approach for the Treatment of Allergic Asthma.

Adoptive Immunity Mediated by HLA-A*0201 Restricted Asp F16 Peptides-Specific CD8+ T Cells Against Aspergillus Fumigatus Infection

Th and Treg response induced by Aspergillus fumigatus pulsed dendritic cells in vitro.

A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus

The function and structure of dendritic cells pulsed with Aspergillus antigens

Innate and Adaptive Immune Responses Induced by Aspergillus Fumigatus Conidia and Hyphae

Use of Aspergillus-pulsed DC in Mice to Enhance Their Host Defense Against Aspergillus Infection

Antigen specificity and cross-reactivity drive functionally diverse anti-Aspergillus fumigatus T cell responses in cystic fibrosis

Human Vγ9Vδ2 T cells exhibit antifungal activity against Aspergillus fumigatus and other filamentous fungi

Dendritic Cells Transduced with an Adenovirus Vector Encoding Interleukin-12 Are a Potent Vaccine for Invasive Pulmonary Aspergillosis

Transient Overexpression of Gamma Interferon Promotes Aspergillus Clearance in Invasive Pulmonary Aspergillosis

CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models

Prediction and Identification of New HLA-A~* 0201-Restricted CD8~+ CTL Epitopes from Aspergillusfumigatus Antigen Asp F16

Influence of Muramyl Dipeptide on the Cytokine Secretion by A549 Cells Stimulated with Aspergillus Fumigatus Conidia and the Possible Mechanisms

Interplay of Cytokines and Chemokines in Aspergillosis

Activation of vitamin D regulates response of human bronchial epithelial cells to Aspergillus fumigatus in an autocrine fashion.

A comprehensive review on the role of T cell subsets and CAR-T cell therapy in Aspergillus fumigatus infection

An IFN-STAT1-CYBB Axis Defines Protective Plasmacytoid DC to Neutrophil Crosstalk During Aspergillus fumigatus Infection.

HIF1-α Upregulation Induces Proinflammatory Factors to Boost Host Killing Capacity after Aspergillus Fumigatus Exposure.